BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Avian flu virus
,
Aspirin
,
rs2230926
,
MDM2
,
Coagulation
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
yl
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hyperoxia
Hypoxia
Effects of reduced temperature
Aging
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Puromycin
Ecdysone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
chico
Cyp6g1
Acf1
PNPLA2
Sod2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Drosophila melanogaster gene expression in adults and 3rd instar larvae after spaceflight
Adult female and male whole flies overexpressing bmm
Drosophila primordial germ cells and somatic cells from wild type and smaug mutants
Altered levels of Cyp6g1 and of Dhr96 in Drosophila
Autosomal dosage compensation in Drosophila DrosDel deficiency lines
Explore Curated Studies Results
Literature
Most Relevant Literature
Genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose t…
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote …
Antifungal Activity of Novel Isoindoline-2-Yl Putrescines as Potential Autophagy-Activated Fungicide…
2-NBDG as a marker for detecting glucose uptake in reactive astrocytes exposed to oxygen-glucose dep…
PI and PIII Ions Supported by BZIMPY Ligands.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
A Phase 1, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Aceta…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ